EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Emerging Role of Sirtuins-Mediated Ferroptosis in Hepatocellular Carcinoma Progression: Mechanisms and Therapeutic Perspectives

Jiangtao Bai, Xuefeng Bai, Jihong Yang, Guodong Yu, Yong Cui

Journal of Hepatocellular Carcinoma · 2026-06 · Volume 13 · 1-21

DOI: 10.2147/jhc.s595693 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-06. Verfasst von Jiangtao Bai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional and Vascular Surgery, Affiliated Hospital of Hebei University, Baoding, Hebei, 071000, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) ranks as the most common type of primary liver cancer, characterized by rapid tumor growth and therapeutic resistance. Evading cell death is a key characteristic of multiple cancers, including HCC. Many programmed cell death (PCD) processes, comprising apoptosis, autophagy, necroptosis, and ferroptosis, have been identified to affect tumor growth and recurrence of HCC. Ferroptosis is an emerging iron-dependent PCD mode characterized by lipid peroxidation and iron accumulation. It has emerged as a critical regulatory mechanism in HCC progression. Sirtuins (SIRTs), a class III histone deacetylases (HDACs) that require NAD + as a cofactor, exhibit exclusive and poised functions in the pathophysiological processes of cancers by mediating ferroptosis. However, a summary of the mechanisms of SIRT-mediated ferroptosis in HCC development and associated therapeutic strategies is limited. This article provides an outline of recent developments in the role of SIRTs in HCC proliferation, metastasis, and the development of multidrug resistance. We highlight the roles and mechanisms of SIRTs in mediating ferroptosis in HCC, aiming to provide a comprehensive and novel perspective for developing diagnostic biomarkers and therapeutic strategies for HCC, thereby advancing the understanding of HCC pathogenesis and treatment. Keywords: sirtuins, hepatocellular carcinoma, ferroptosis, molecular mechanism, progression

Schlagwörter

Stichwörter der Autor:innen

ferroptosishepatocellular carcinomamolecular mechanismprogressionsirtuins

Autor:innen und Institutionen

  • Department of Interventional and Vascular Surgery, Affiliated Hospital of Hebei University, Baoding, Hebei, 071000, People's Republic of China.
  • Department of Hepatobiliary Surgery, Affiliated Hospital of Hebei University, Baoding, People's Republic of China.

Zitieren

APA

Bai, J., Bai, X., Yang, J., Yu, G., & Cui, Y. (2026). Emerging Role of Sirtuins-Mediated Ferroptosis in Hepatocellular Carcinoma Progression: Mechanisms and Therapeutic Perspectives. Journal of Hepatocellular Carcinoma, Volume 13, 1-21. https://doi.org/10.2147/jhc.s595693

Vancouver

Bai J, Bai X, Yang J, Yu G, Cui Y. Emerging Role of Sirtuins-Mediated Ferroptosis in Hepatocellular Carcinoma Progression: Mechanisms and Therapeutic Perspectives. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-21. doi:10.2147/jhc.s595693

BibTeX
@article{Bai2026,
  author = {Bai, Jiangtao and Bai, Xuefeng and Yang, Jihong and Yu, Guodong and Cui, Yong},
  title = {Emerging Role of Sirtuins-Mediated Ferroptosis in Hepatocellular Carcinoma Progression: Mechanisms and Therapeutic Perspectives},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2026},
  volume = {Volume 13},
  pages = {1--21},
  doi = {10.2147/jhc.s595693}
}
Kostenlos starten →